215 related articles for article (PubMed ID: 21699855)
41. [Device associated complications].
Butter C; Stellbrink C
Herzschrittmacherther Elektrophysiol; 2013 Sep; 24(3):139-40. PubMed ID: 23925511
[No Abstract] [Full Text] [Related]
42. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
Margey R
J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
[TBL] [Abstract][Full Text] [Related]
43. Nonstaphylococcal infections of cardiac implantable electronic devices.
Viola GM; Awan LL; Darouiche RO
Circulation; 2010 May; 121(19):2085-91. PubMed ID: 20439783
[TBL] [Abstract][Full Text] [Related]
44. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections.
Habib A; Irfan M; Baddour LM; Le KY; Anavekar NS; Lohse CM; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Sohail MR;
Europace; 2013 Feb; 15(2):227-35. PubMed ID: 22956593
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for mortality in patients with cardiac device-related infection.
Baman TS; Gupta SK; Valle JA; Yamada E
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):129-34. PubMed ID: 19808457
[TBL] [Abstract][Full Text] [Related]
46. Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators.
Post JJ; Alexopoulos C; Fewtrell C; Giles R; Jones PD
Intern Med J; 2006 Dec; 36(12):790-2. PubMed ID: 17096742
[TBL] [Abstract][Full Text] [Related]
47. Contemporary management of cardiovascular implantable electronic device infections.
Sohail MR; Sultan OW; Raza SS
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):831-9. PubMed ID: 20586567
[TBL] [Abstract][Full Text] [Related]
48. Infections of implantable cardiac rhythm devices: predisposing factors and outcome.
Ipek EG; Guray U; Demirkan B; Guray Y; Aksu T
Acta Cardiol; 2012 Jun; 67(3):303-10. PubMed ID: 22870738
[TBL] [Abstract][Full Text] [Related]
49. Management of cardiac device infections: A retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal.
Tascini C; Bongiorni MG; Gemignani G; Soldati E; Leonildi A; Arena G; Doria R; Giannola G; La Pira F; Tagliaferri E; Caravelli P; Dell'Anna R; Menichetti F
J Chemother; 2006 Apr; 18(2):157-63. PubMed ID: 16736884
[TBL] [Abstract][Full Text] [Related]
50. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
[TBL] [Abstract][Full Text] [Related]
51. Vegetation size marker for extraction technique?
Maloney JD; Maloney JD
J Am Coll Cardiol; 2010 Mar; 55(9):895-7. PubMed ID: 20185040
[No Abstract] [Full Text] [Related]
52. Extraction of superfluous device leads: A comparison with removal of infected leads.
Huang XM; Fu H; Osborn MJ; Asirvatham SJ; McLeod CJ; Glickson M; Acker NG; Friedman PA; Cha YM
Heart Rhythm; 2015 Jun; 12(6):1177-82. PubMed ID: 25661776
[TBL] [Abstract][Full Text] [Related]
53. Cardiac implanted electronic device-related infective endocarditis: clinical features, management, and outcomes of 80 consecutive patients.
Kim DH; Tate J; Dresen WF; Papa FC; Bloch KC; Kalams SA; Ellis CR; Baker MT; Lenihan DJ; Mendes LA
Pacing Clin Electrophysiol; 2014 Aug; 37(8):978-85. PubMed ID: 25060820
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of cardiac device-related infective endocarditis after device removal.
Le Dolley Y; Thuny F; Mancini J; Casalta JP; Riberi A; Gouriet F; Bastard E; Ansaldi S; Franceschi F; Renard S; Prevot S; Giorgi R; Tafanelli L; Avierinos JF; Raoult D; Deharo JC; Habib G
JACC Cardiovasc Imaging; 2010 Jul; 3(7):673-81. PubMed ID: 20633844
[TBL] [Abstract][Full Text] [Related]
55. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
57. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.
Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Jenkins SM; Baddour LM
Mayo Clin Proc; 2008 Jan; 83(1):46-53. PubMed ID: 18174000
[TBL] [Abstract][Full Text] [Related]
58. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients.
Hickson LJ; Gooden JY; Le KY; Baddour LM; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Sohail MR
Am J Kidney Dis; 2014 Jul; 64(1):104-10. PubMed ID: 24388672
[TBL] [Abstract][Full Text] [Related]
59. Mortality and cost associated with cardiovascular implantable electronic device infections.
Sohail MR; Henrikson CA; Braid-Forbes MJ; Forbes KF; Lerner DJ
Arch Intern Med; 2011 Nov; 171(20):1821-8. PubMed ID: 21911623
[TBL] [Abstract][Full Text] [Related]
60. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry.
Chung MK; Holcomb RG; Mittal S; Steinberg JS; Gleva MJ; Mela T; Uslan DZ; Mitchell K; Poole JE;
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1048-56. PubMed ID: 25221331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
